Evidence map›Paper›PMID 31419338›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2020

Mobile e-diary application facilitates the monitoring of patient-reported outcomes and a high treatment adherence for clinical trials in dermatology.

M Rijsbergen, T Niemeyer-van der Kolk, R Rijneveld, J H F M Pinckaers, I Meshcheriakov, J N Bouwes Bavinck, M B A van Doorn, G Hogendoorn, G Feiss, A F Cohen and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Observational
  7. Early Detection of Lower Adherence to Long-Term e-Diary Recording: A Checkpoint to Target Early Educational Intervention in Seasonal Allergic Rhinitis?Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Innovative Approaches to Enhance and Measure Medication Adherence in Chronic Disease Management: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Development of a core outcome domain set for clinical research on capillary malformations (the COSCAM project).Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

M RijsbergenCentre for Human Drug Research, Leiden, The Netherlands.
T Niemeyer-van der KolkCentre for Human Drug Research, Leiden, The Netherlands.
R RijneveldCentre for Human Drug Research, Leiden, The Netherlands.
J H F M PinckaersCentre for Human Drug Research, Leiden, The Netherlands.
I MeshcheriakovCentre for Human Drug Research, Leiden, The Netherlands.
J N Bouwes BavinckDepartment of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
M B A van DoornDepartment of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands.
G HogendoornCentre for Human Drug Research, Leiden, The Netherlands.
G FeissCutanea Life Science, Wayne, Pennsylvania, USA.
A F CohenCentre for Human Drug Research, Leiden, The Netherlands.
J BurggraafCentre for Human Drug Research, Leiden, The Netherlands.
M I E van PoelgeestCentre for Human Drug Research, Leiden, The Netherlands.
R RissmannCentre for Human Drug Research, Leiden, The Netherlands.
Centre for Human Drug Research · NLErasmus MC · NLLeiden University · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAssessment of treatment effects in clinical trials requires valid information on treatment adherence, adverse events and symptoms. Paper-based diaries are often inconvenient and have limited reliability, particularly for outpatient trials.

objectivesTo investigate the utility of an electronic diary (e-diary) application for patients with skin diseases in outpatient clinical trials.

methodsAn e-diary application was developed and technically validated. Treatment adherence was defined as topical administration by the patient, and patient-reported outcomes, i.e. pain and itch, were evaluated by the e-diary in six clinical trials on newly tested topical drugs. Additionally, the proportion of patients capturing the applied topical drug by camera and filling in the pain and itch scores was defined as e-diary adherence, and patients' perception of usefulness and acceptability of the e-diary were evaluated.

resultsTreatment adherence rates of the included 256 patients were high (median 98%, range 97-99%). E-diary adherence was also high with a median of 93% (range 87-97%) for capturing the applied drug by camera, and 89% (range 87-96%) and 94% (range 87-96%) for entering respectively the itch and pain score. Daily symptom scores provided good insights into the disease burden, and patients rated the e-diary as good to excellent with respect to user acceptability.

conclusionsThe results suggest that the e-diary is an excellent way to ensure proper treatment administration, indicated by both the high user acceptability scores and high treatment adherence. Moreover, the e-diary may also be valuable for frequent and reliable monitoring of patient-reported outcomes in daily clinical practice.

Indexed as

Diaries as TopicMobile ApplicationsPatient Reported Outcome MeasuresTreatment Adherence and ComplianceAdolescentAdultClinical Trials as TopicFemaleHumansMaleMiddle AgedSkin DiseasesYoung Adult

Identifiers

PMID31419338
PMCPMC7064941
OpenAlexW2967201906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.